Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
175M
-
Number of holders
-
270
-
Total 13F shares, excl. options
-
75.9M
-
Shares change
-
-1.29M
-
Total reported value, excl. options
-
$4.4B
-
Value change
-
-$62.3M
-
Put/Call ratio
-
1.24
-
Number of buys
-
152
-
Number of sells
-
-106
-
Price
-
$58.05
Significant Holders of Teladoc Health, Inc. - Common Stock (TDOC) as of Q2 2018
312 filings reported holding TDOC - Teladoc Health, Inc. - Common Stock as of Q2 2018.
Teladoc Health, Inc. - Common Stock (TDOC) has 270 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75.9M shares
of 175M outstanding shares and own 43.24% of the company stock.
Largest 10 shareholders include FMR LLC (8.7M shares), BlackRock Inc. (5.32M shares), VANGUARD GROUP INC (4.63M shares), JPMORGAN CHASE & CO (4.42M shares), ALLIANCEBERNSTEIN L.P. (3.19M shares), WELLINGTON MANAGEMENT GROUP LLP (2.83M shares), EAGLE ASSET MANAGEMENT INC (2.01M shares), BAMCO INC /NY/ (1.9M shares), BANK OF AMERICA CORP /DE/ (1.88M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1.85M shares).
This table shows the top 270 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.